Knee Arthritis Hip Arthritis Shoulder Injuries Back Arthritis and Pain Small Joints
Small Joints

At CellMark360, we’re advancing the field of regenerative medicine by offering personalized, cell-based therapies that support healing in small joints affected by arthritis, injury, or overuse. Using autologous stromal vascular fraction (SVF) and adipose-derived stem cells (ADSCs) sourced from your own fat tissue, our treatments promote natural repair, reduce inflammation, and aim to restore mobility. Small joints—such as those in the hands, wrists, feet, and ankles—are especially vulnerable to wear-and-tear and autoimmune conditions like rheumatoid arthritis. While our therapies are supported by peer-reviewed research and have shown promise in treating joint pain and early-stage degeneration, they may not be suitable for severe deformities or complete joint collapse. Careful patient evaluation is key. Whether you're a patient looking for non-surgical options to ease joint discomfort or a physician seeking to expand treatment tools, our regenerative approach provides a safe and effective pathway to relief in small joint conditions.

Why Choose Autologous Adipose-Derived Therapies?

Adipose tissue—your body’s own fat—is a rich, accessible source of regenerative cells, making it an ideal choice for personalized healing. At CellMark360, we use your own cells to ensure safety and compatibility, eliminating risks like immune rejection or disease transmission while adhering to FDA guidelines for minimal manipulation. Our approach focuses on two powerful components derived from adipose tissue:

Stromal Vascular Fraction (SVF): A Natural Healing Powerhouse

SVF is a diverse mix of cells extracted from your adipose tissue, including adipose-derived mesenchymal stem cells (ADSCs), pericytes, endothelial progenitor cells, fibroblasts, and immune cells [3][17]. Using our FDA 510(k)-cleared CellVault device, we isolate SVF in a sterile, automated process that takes under two hours, allowing your cells to be used in the same procedure to support healing.

Adipose-Derived Mesenchymal Stem Cells (ADSCs): Targeted Regeneration

ADSCs are mesenchymal stem cells from your adipose tissue that reduce inflammation and promote tissue repair [4]. These cells are young, robust, and abundant in adipose tissue, offering 500 to 2000 times more stem cells than bone marrow, making them a potent tool for regeneration.

Healing Back Pain with SVF and ADSCs

Chronic back pain, often caused by arthritis, injuries, or degenerative conditions, can drastically affect daily life. At CellMark360, we’ve seen how SVF offers a minimally invasive solution to help patients regenerate damaged tissues and restore function. While the studies below focus on joint conditions, the principles of SVF and ADSCs apply directly to back pain. These therapies deliver your own regenerative cells to damaged areas, encouraging natural healing processes to repair tissues and reduce discomfort [46][47]. For those with back arthritis or injuries, SVF provides a promising option to support recovery without invasive surgery, offering a path to lasting relief [25][27][28].

Results Across Joint Conditions

Our commitment to scientific integrity is backed by a robust body of peer-reviewed research supporting the efficacy of SVF and ADSCs. Below, we highlight key findings from studies on various joint conditions, demonstrating the potential of these therapies for healing and restoration—principles that extend to back pain applications.

Small Joint Arthritis of the Hand

For patients with hand arthritis, SVF has shown remarkable results. A study on rheumatoid arthritis of the hand found that a single SVF injection led to a 91.3% improvement in functional hand score (FHS) and a 91% reduction in pain, as measured by the visual analog scale (VAS), after six months [9]. Grip strength also improved by 59%, showcasing significant functional gains [9].
The study recommends a minimum dose of 3×10^6 cells per hand for optimal results [9].Another study of 19 patients (30 hands) with trapeziometacarpal osteoarthritis (stages 1-4) used a combination of SVF, ADSCs, and platelet-rich plasma. Patients experienced significant pain reduction at 6 and 24 months, with improvements in pinch strength, demonstrating the potential for long-term relief [8][30].

Tennis Elbow (Lateral Epicondylosis)

Tennis elbow, a painful overuse injury, has also responded well to adipose-derived therapies [23][24]. In a study of 18 tennis players with chronic tennis elbow, a single injection of ADSCs resulted in significant clinical improvement and structural repair of the tendon over 12 months, as confirmed by MRI [5]. Another study using allogeneic ADSCs reported a dramatic drop in VAS pain scores from 66.8 to 14.8 and improved elbow performance scores from 64.0 to 90.6 after 52 weeks, with reduced tendon defects and no serious side effects [6].

Ankle Pathologies

A systematic review of ADSCs for ankle conditions, such as osteochondral lesions and osteoarthritis, found consistent improvements in clinical outcomes [10]. Cell isolation methods, like those used by CellMark360, were noted as particularly effective, with no serious complications reported [10]. While more research is needed, these findings highlight the potential for ADSCs to support healing in weight-bearing joints—a principle that can extend to the spine [46].

Carpometacarpal (CMC) Joint Arthritis

Thumb arthritis can severely limit hand function, but SVF offers a promising solution. A literature review of autologous fat injections for thumb CMC arthritis reported consistent pain reduction and improved hand function across all studies [7]. A retrospective study of 30 hands also confirmed significant pain relief at 6 and 24 months, with enhanced pinch strength and no complications, suggesting SVF could delay the need for surgery [8]. Another review echoed these findings, noting improvements in pain, daily activities, hand strength, and patient satisfaction, though it highlighted the need for standardized techniques [11].

Temporomandibular Joint (TMJ) Arthritis

For TMJ arthritis, which causes jaw pain and limited movement, adipose-derived therapies have shown potential [39]. A randomized trial comparing microfragmented adipose tissue to hyaluronic acid injections found that the adipose group had a higher success rate in reducing pain and improving mouth opening [15]. Preclinical studies also suggest that ADSCs can support cartilage repair and reduce inflammation in TMJ arthritis [15].

A Safe and Reliable Option

Safety is a cornerstone of CellMark360’s mission. A multi-center analysis of SVF therapy involving 676 patients reported an excellent safety profile, with only mild, temporary side effects like soreness at the harvest site or occasional headaches [19]. Studies on specific joint conditions, such as tennis elbow and CMC arthritis, also reported no serious adverse effects over extended follow-up periods [6][8]. With CellMark360, you can trust that our therapies are both effective and safe, prioritizing your well-being.

Limitations and the Path Forward

While the evidence for SVF and ADSCs is promising, challenges remain. Studies vary in cell isolation methods, sample sizes, and follow-up duration, and many include additional therapies, making it harder to isolate the effects of SVF alone [16][18][21][33]. At CellMark360, we’re committed to advancing research by standardizing protocols, determining optimal cell doses, and supporting larger, long-term studies to ensure the best outcomes for patients.

Why CellMark360?

CellMark360 isn’t just about providing cutting-edge technology—it’s about empowering physicians and patients with a complete solution. Our CellVault device simplifies the isolation of SVF, delivering the highest number of viable cells for better outcomes. We also offer clinical training, marketing support, access to outcome data, and a network of regenerative medicine experts to ensure your success. For patients with back pain, our approach offers a natural, minimally invasive way to heal, helping you restore function and reclaim your life.

Ready to explore how CellMark360 can help you or your patients? Visit www.CellMark360.com to learn more or schedule a consultation.

References